BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
11:56 am
Sale		 2022-12-31 13G Cogent Biosciences, Inc.
COGT		 BIOTECHNOLOGY VALUE FUND L P 984,824
1.400%		 -2,129,708decrease
(-68.38%)		 Filing
2022-02-14
1:38 pm
Purchase		 2021-12-31 13G Cogent Biosciences, Inc.
COGT		 BIOTECHNOLOGY VALUE FUND L P 3,114,532
7.500%		 282increase
(+0.01%)		 Filing
2021-02-11
4:52 pm
Purchase		 2020-12-31 13G Cogent Biosciences, Inc.
COGT		 BIOTECHNOLOGY VALUE FUND L P 3,114,250
4.700%		 3,114,250increase
(New Position)		 Filing